MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2025 International Congress

    Adherence with Digital Outcome Measures in Focal Dystonias

    A. Tingin, P. Reyes, F. Qeadan, L. Wright, G. Kilic-Berkmen, S. Bellows, S. Fox, D. Martino, J. Feuerstein, A. Wagle Shukla, A. Deik, R. Barbano, B. Berman, J. Perlmutter, H. Jinnah, S. Pirio Richardson (Albuquerque, USA)

    Objective: We assessed patient adherence with an app-based patient-centered outcome (PCO) tool for focal dystonia in a prospective study to determine the impact of dystonia…
  • 2025 International Congress

    Challenges in Airway Management after Deep Brain Stimulation in DYT1 Dystonia: a Case Report

    CE. Wang, CF. Hu, YH. Chen, YF. Sung (Taipei City, Taiwan)

    Objective: To highlight the challenges in upper airway management following deep brain stimulation (DBS) in patients with severe, medically refractory DYT1 dystonia and to emphasize…
  • 2025 International Congress

    National Survey of DYT/PARK-GCH1 (Segawa Disease) in Japan

    K. Hoshino, M. Kawai, Y. Nagao, M. Nozaki, Y. Yatomi, Y. Hirano, M. Fukumizu, I. Kawahata, H. Shintaku, K. Kimura, M. Hayashi (Osaka, Japan)

    Objective: To clarify clinical features of Segawa Disease (SD) in Japan. Background: Prof Segawa discovered SD 50 years ago, and GCH-1 gene mutations were linked…
  • 2025 International Congress

    Long-Term Therapeutic Effect of Botulinum Neurotoxin Type A (BoNT-A) in Cervical Dystonia: A Case Series.

    R. Lopez-Castellanos, R. Lopez-Contreras (Boston, USA)

    Objective: To evaluate the long-term therapeutic effect of Botulinum neurotoxin type A (BoNT-A) in cervical dystonia. Background: Cervical dystonia is the most common adult-onset focal…
  • 2025 International Congress

    The Vodka Trial: Clinical and Genetic Characteristics of Alcohol Responsiveness in Laryngeal Dystonia

    L. O'Flynn, A. Domingo, A. Hamzehei Sichani, A. Nishiyama, M. Hincher, R. Yadav, L. Ozelius, K. Simonyan (Boston, USA)

    Objective: To determine the objective characteristics of alcohol responsiveness in laryngeal dystonia (LD) using a standardized alcohol challenge test and genetic testing. Background: LD is…
  • 2025 International Congress

    GPi-DBS responsive laryngeal dystonia in SGCE myoclonus-dystonia

    S. Nagaratnam, D. Wilson, L. Williams, S. Xi, L. Natsis, J. Mcmaster, N. Mahant (Westmead, Australia)

    Objective: To describe a case of DBS-responsive laryngeal dystonia in the setting of myoclonus-dystonia secondary to e-sarcoglycan (SGCE) mutation. Background: DBS is emerging as a…
  • 2025 International Congress

    Understanding Family and Clinician Perspectives on Treatment Decision-Making for Acute Dystonia Exacerbations in Children

    L. Vogt, A. Leblanc-Millar, S. Breitbart, N. Al Azri, A. Fasano, K. Nelson, C. Gorodetsky (Toronto, Canada)

    Objective: Primary: To identify factors influencing the decision to provide acute pharmacological treatment for dystonia exacerbations in hospitalized pediatric patients. Secondary: To assess the alignment…
  • 2025 International Congress

    Development and Testing of a Smartphone Application to Capture Patient-Centered Outcome (PCO) Measures for Dystonia

    P. Reyes, A. Tingin, B. Berman, S. Schneider, J. Hieshetter, K. Kuman, G. Kilic-Berkmen, L. Wright, F. Qeadan, J. Perlmutter, H. Jinnah, S. Pirio-Richardson (Richmond, USA)

    Objective: Develop a smartphone application to collect patient-centered outcome (PCO) measures for dystonia. Background: PCO measures tailored for each major adult-onset focal dystonia subtype (Cervical…
  • 2024 International Congress

    Is acute dystonia in a teenager psychogenic dystonia?

    G. Ilina, D. Khasanova, Z. Zalyalova, A. Lestrovaya (Kazan, Russian Federation)

    Objective: To compare literature data on psychogenic tremor and clinical and MRI data of the patient. Background: Dystonia is a involuntary, sustained or repetitive, patterned…
  • 2024 International Congress

    Effective Management of Generalized Dystonia with Unilateral Deep Brain Stimulation – Killing Two Birds with One Stone?

    K. Massruha, I. Brum, C. Listik, J. Yamamoto, S. Casagrande, M. Belo Silva, P. Medeiros Lacerda, V. Zanesi Maciel, R. Cury, E. Barbosa (São Paulo, Brazil)

    Objective: Managing generalized dystonia in adults is challenging despite pharmacological interventions due to suboptimal response or intolerable side effects. While bilateral Globus Pallidus internus Deep…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley